Sonoma Pharmaceuticals Stock (NASDAQ: SNOA) stock price, news, charts, stock research, profile.
Open | $0.165 |
Close | - |
Volume / Avg. | 46.690K / 1.424M |
Day Range | 0.160 - 0.166 |
52 Wk Range | 0.116 - 1.520 |
Market Cap | $2.653M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 52 |
Short Interest | 0.2% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Sonoma Pharmaceuticals (NASDAQ: SNOA) through any online brokerage.
Other companies in Sonoma Pharmaceuticals’s space includes: Cingulate (NASDAQ:CING), NovaBay Pharmaceuticals (AMEX:NBY), cbdMD (AMEX:YCBD), 60 Degrees (NASDAQ:SXTP) and Akanda (NASDAQ:AKAN).
The latest price target for Sonoma Pharmaceuticals (NASDAQ: SNOA) was reported by Ladenburg Thalmann on Tuesday, September 5, 2023. The analyst firm set a price target for 3.25 expecting SNOA to rise to within 12 months (a possible 1902.77% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Sonoma Pharmaceuticals (NASDAQ: SNOA) is $0.162275 last updated Today at April 26, 2024 at 10:54 AM EDT.
There are no upcoming dividends for Sonoma Pharmaceuticals.
Sonoma Pharmaceuticals’s Q4 earnings are confirmed for Thursday, June 20, 2024.
There is no upcoming split for Sonoma Pharmaceuticals.
Sonoma Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.